logo
logo
Sign in

Tissue Banking Market Set For Strong Growth Accelerated by Increased Demand for Regenerative Medicine

avatar
Lucy Kart
Tissue Banking Market Set For Strong Growth Accelerated by Increased Demand for Regenerative Medicine


Tissue banking refers to the storage of human tissue, umbilical cord blood, and placenta cells for future use in transplantation and regenerative medicine applications. Tissue banking provides the advantages of immediate availability of transplant tissues whenever required instead of waiting for a donor. The rising prevalence of chronic diseases and genetic disorders has increased the demand for tissue and organ transplantation.

The Global Tissue Banking Market is estimated to be valued at US$ 1.81 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Increased demand for regenerative medicine has accelerated the growth of the Tissue Banking Market over the forecast period. Regenerative medicine utilizes adult stem cells from umbilical cord blood, bone marrow, and adipose tissue for treating chronic diseases. It helps repair or replace damaged cells and tissues. Advantages such as low risk of rejection and ability to differentiate into various cell types have increased the scope of regenerative medicine applications. This will subsequently drive the demand for storing and processing various types of human tissues and stem cells. Further research to develop advanced regenerative therapies using stem cells from tissue banks is anticipated to present lucrative opportunities for market growth during the forecast period.

Segment Analysis

The Global Tissue Banking Market is segmented on the basis of application and end user. The application segments include cardiovascular tissue, lung tissue, kidney tissue, pancreatic tissue, brain tissue, and others. The cardiovascular tissue segment currently dominates the market due to high prevalence of cardiovascular diseases and increasing number of organ transplant surgeries.

Key Takeaways

Global Tissue Banking Market Demand is expected to witness high growth during the forecast period of 2023 to 2030. The market size for 2023 is estimated to be US$ 1.81 Bn.

Regional analysis

North America region currently dominates the Global Tissue Banking Market. This is mainly attributed to advanced healthcare infrastructure, rising technological advancements, and growing prevalence of chronic and lifestyle diseases in the region. The Asia Pacific region is expected to witness fastest growth over the forecast period owing to increasing healthcare expenditure, growing geriatric population, and rising awareness regarding tissue banking.

Key players

Key players operating in the Tissue Banking Market are AbD Serotec, AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.


Get More Insights on this Topic- https://www.dailyprbulletin.com/tissue-banking-market-size-share-and-demand-analysis/ 

collect
0
avatar
Lucy Kart
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more